
Profitability, historical returns, and peer comparisons.
According to Ortivus AB (publ)’s latest financial reports and current stock price. The company's current ROE is -183.13%. This represents a change of 2.24% compared to the average of -7.81% of the last 4 quarters.
The mean historical ROE of Ortivus AB (publ) over the last ten years is -75.70%. The current -183.13% ROE has changed 141.93% with respect to the historical average. Over the past ten years (40 quarters), ORTI-A.ST's ROE was at its highest in in the December 2024 quarter at 134.61%. The ROE was at its lowest in in the September 2024 quarter at -190.26%.
Average
-75.70%
Median
-86.10%
Minimum
-613.98%
Maximum
347.56%
Discovering the peaks and valleys of Ortivus AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 722.97%
Maximum Annual ROE = 347.56%
Minimum Annual Increase = -734.08%
Minimum Annual ROE = -613.98%
| Year | ROE | Change |
|---|---|---|
| 2025 | -97.60% | -128.08% |
| 2024 | 347.56% | -429.66% |
| 2023 | -105.43% | -734.08% |
| 2022 | 16.63% | -46.85% |
| 2021 | 31.28% | -45.68% |
| 2020 | 57.59% | -131.50% |
| 2019 | -182.84% | -70.22% |
| 2018 | -613.98% | 722.97% |
| 2017 | -74.61% | -44.96% |
| 2016 | -135.56% | 136.38% |
The current ROE of Ortivus AB (publ) (ORTI-A.ST) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
48.18%
5-year avg
38.49%
10-year avg
-75.70%
Ortivus AB (publ)’s ROE is less than Newbury Pharmaceuticals AB (publ) (0%), less than Simris Alg AB (publ) (1.21%), greater than ExpreS2ion Biotech Holding AB (publ) (-104.71%), greater than AcouSort AB (-76.74%), greater than OncoZenge AB (publ) (-2775.09%), greater than Lipigon Pharmaceuticals AB (publ) (-153.64%), less than Aino Health AB (publ) (133.94%), greater than ScandiDos AB (publ) (-18.89%), greater than Modus Therapeutics Holding AB (-177.45%), greater than Scandinavian Real Heart AB (Publ) (-54.68%),
| Company | ROE | Market cap |
|---|---|---|
| 0% | $50.31M | |
| 1.21% | $168.05M | |
| -104.71% | $2.68M | |
| -76.74% | $71.11M | |
| -2775.09% | $45.66M | |
| -153.64% | $908.90K | |
| 133.94% | $35.19M | |
| -18.89% | $40.98M | |
| -177.45% | $17.14M | |
| -54.68% | $135.96M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ortivus AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ortivus AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Ortivus AB (publ)'s ROE?
How is the ROE calculated for Ortivus AB (publ) (ORTI-A.ST)?
What is the highest ROE for Ortivus AB (publ) (ORTI-A.ST)?
What is the 3-year average ROE for Ortivus AB (publ) (ORTI-A.ST)?
What is the 5-year average ROE for Ortivus AB (publ) (ORTI-A.ST)?
How does the current ROE for Ortivus AB (publ) (ORTI-A.ST) compare to its historical average?